94 related articles for article (PubMed ID: 22119778)
41. Suppressive Role of PPARγ-Regulated Endothelial Nitric Oxide Synthase in Adipocyte Lipolysis.
Yamada Y; Eto M; Ito Y; Mochizuki S; Son BK; Ogawa S; Iijima K; Kaneki M; Kozaki K; Toba K; Akishita M; Ouchi Y
PLoS One; 2015; 10(8):e0136597. PubMed ID: 26317347
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison.
Villela D; Leonhardt J; Patel N; Joseph J; Kirsch S; Hallberg A; Unger T; Bader M; Santos RA; Sumners C; Steckelings UM
Clin Sci (Lond); 2015 Feb; 128(4):227-34. PubMed ID: 25328009
[TBL] [Abstract][Full Text] [Related]
43. Increased vascular sympathetic modulation in mice with Mas receptor deficiency.
Rabello Casali K; Ravizzoni Dartora D; Moura M; Bertagnolli M; Bader M; Haibara A; Alenina N; Irigoyen MC; Santos RA
J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316643643. PubMed ID: 27080540
[TBL] [Abstract][Full Text] [Related]
44. Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.
Pinheiro SVB; Ferreira AJ; Kitten GT; da Silveira KD; da Silva DA; Santos SHS; Gava E; Castro CH; Magalhães JA; da Mota RK; Botelho-Santos GA; Bader M; Alenina N; Santos RAS; Simoes E Silva AC
Kidney Int; 2009 Jun; 75(11):1184-1193. PubMed ID: 19262461
[TBL] [Abstract][Full Text] [Related]
45. Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction.
Rabelo LA; Xu P; Todiras M; Sampaio WO; Buttgereit J; Bader M; Santos RA; Alenina N
J Am Soc Hypertens; 2008; 2(6):418-24. PubMed ID: 20409925
[TBL] [Abstract][Full Text] [Related]
46. Role of the receptor Mas in macrophage-mediated inflammation in vivo.
Hammer A; Yang G; Friedrich J; Kovacs A; Lee DH; Grave K; Jörg S; Alenina N; Grosch J; Winkler J; Gold R; Bader M; Manzel A; Rump LC; Müller DN; Linker RA; Stegbauer J
Proc Natl Acad Sci U S A; 2016 Dec; 113(49):14109-14114. PubMed ID: 27872279
[TBL] [Abstract][Full Text] [Related]
47. Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies.
Burghi V; Fernández NC; Gándola YB; Piazza VG; Quiroga DT; Guilhen Mario É; Felix Braga J; Bader M; Santos RAS; Dominici FP; Muñoz MC
PLoS One; 2017; 12(8):e0183278. PubMed ID: 28813513
[TBL] [Abstract][Full Text] [Related]
48. Development of lipid metabolism in ovine preadipocytes in vitro.
Soret B; Melrose SE; Finley E; Travers MT; Houslay MD; Vernon RG
Biochem Soc Trans; 1997 Nov; 25(4):S671. PubMed ID: 9450099
[No Abstract] [Full Text] [Related]
49. Characterization of the hydroxycarboxylic acid receptor 2 in cats.
Graff EC; Norris OC; Sandey M; Kemppainen RJ; Judd RL
Domest Anim Endocrinol; 2015 Oct; 53():88-94. PubMed ID: 26164006
[TBL] [Abstract][Full Text] [Related]
50. Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene.
Walther T; Wessel N; Kang N; Sander A; Tschöpe C; Malberg H; Bader M; Voss A
Braz J Med Biol Res; 2000 Jan; 33(1):1-9. PubMed ID: 10625868
[TBL] [Abstract][Full Text] [Related]
51. The Meaning of Mas.
Bader M; Alenina N; Young D; Santos RAS; Touyz RM
Hypertension; 2018 Nov; 72(5):1072-1075. PubMed ID: 30354821
[No Abstract] [Full Text] [Related]
52. Involvement of the metabolic sensor GPR81 in cardiovascular control.
Wallenius K; Thalén P; Björkman JA; Johannesson P; Wiseman J; Böttcher G; Fjellström O; Oakes ND
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978803
[TBL] [Abstract][Full Text] [Related]
53. Ablation of Pparg2 impairs lipolysis and reveals murine strain differences in lipolytic responses.
Rodriguez-Cuenca S; Carobbio S; Vidal-Puig A
FASEB J; 2012 May; 26(5):1835-44. PubMed ID: 22319009
[TBL] [Abstract][Full Text] [Related]
54. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms.
Al-Lahham SH; Peppelenbosch MP; Roelofsen H; Vonk RJ; Venema K
Biochim Biophys Acta; 2010 Nov; 1801(11):1175-83. PubMed ID: 20691280
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin-(1-7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice.
Järve A; Qadri F; Todiras M; Schmolke S; Alenina N; Bader M
Front Physiol; 2020; 11():203. PubMed ID: 32226394
[TBL] [Abstract][Full Text] [Related]
56. A clinical link between peroxisome proliferator-activated receptor γ and the renin-angiotensin system.
Sigmund CD
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):676-8. PubMed ID: 23486770
[TBL] [Abstract][Full Text] [Related]
57. [Oxidized free fatty acids as lipid mediators and functions of G2A as their receptor].
Kishimoto K; Obinata H; Kishi M; Ohshima N; Tatei K; Izumi T
Seikagaku; 2011 Jun; 83(6):545-54. PubMed ID: 21800685
[No Abstract] [Full Text] [Related]
58. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.
Lautner RQ; Villela DC; Fraga-Silva RA; Silva N; Verano-Braga T; Costa-Fraga F; Jankowski J; Jankowski V; Sousa F; Alzamora A; Soares E; Barbosa C; Kjeldsen F; Oliveira A; Braga J; Savergnini S; Maia G; Peluso AB; Passos-Silva D; Ferreira A; Alves F; Martins A; Raizada M; Paula R; Motta-Santos D; Klempin F; Pimenta A; Alenina N; Sinisterra R; Bader M; Campagnole-Santos MJ; Santos RA
Circ Res; 2013 Apr; 112(8):1104-11. PubMed ID: 23446738
[TBL] [Abstract][Full Text] [Related]
59. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.
Molaei A; Molaei E; Hayes AW; Karimi G
Cell Cycle; 2023 Jul; 22(13):1654-1674. PubMed ID: 37365840
[TBL] [Abstract][Full Text] [Related]
60. Early onset of aging phenotype in vascular repair by Mas receptor deficiency.
Vasam G; S SJ; Miyat SY; Adam H; Jarajapu YP
Geroscience; 2022 Feb; 44(1):311-327. PubMed ID: 34661816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
